Background-The Pediatric Heart Network trial comparing outcomes in 549 infants with single right ventricle undergoing a Norwood procedure randomized to modified Blalock-Taussig shunt or right ventricle-pulmonary artery shunt (RVPAS) found better 1-year transplant-free survival in those who received RVPAS. We sought to compare the impact of shunt type on echocardiographic indices of cardiac size and function up to 14 months of age. Methods and Results-A core laboratory measured indices of cardiac size and function from protocol exams: early after Norwood procedure (age 22.5Ϯ13.4 days), before stage II procedure (age 4.8Ϯ1.8 months), and at 14 months (age 14.3Ϯ1.2 months). Mean right ventricular ejection fraction was Ͻ50% at all intervals for both groups and was higher in the RVPAS group after Norwood procedure (49Ϯ7% versus 44Ϯ8%; PϽ0.001) but was similar by 14 months. Tricuspid and neoaortic regurgitation, diastolic function, and pulmonary artery and arch dimensions were similar in the 2 groups at all intervals. Neoaortic annulus area (4.2Ϯ1.2 versus 4.9Ϯ1.2 cm 2 /m 2 ), systolic ejection times (214.0Ϯ29.4 versus 231.3Ϯ28.6 ms), neoaortic flow (6.2Ϯ2.4 versus 9.4Ϯ3.4 L/min per square meter), and peak arch velocity (1.9Ϯ0.7 versus 2.2Ϯ0.7 m/s) were lower at both interstage examinations in the RVPAS compared with the modified Blalock-Taussig shunt group (PϽ0.001 for all), but all were similar at 14 months. Conclusions-Indices of cardiac size and function after the Norwood procedure are similar for modified Blalock-Taussig shunt and RVPAS by 14 months of age. Interstage differences between shunt types can likely be explained by the physiology created when the shunts are in place rather than by intrinsic differences in cardiac function. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00115934. (Circulation. 2012;125:2630-2638.) Key Words: echocardiography Ⅲ hypoplastic left heart syndrome Ⅲ Norwood Ⅲ single ventricle T he Norwood procedure 1 is used to palliate neonates with hypoplastic left heart syndrome and other single right ventricle (RV) anomalies. Two techniques are presently used to provide pulmonary blood flow in this operation. The modified Blalock-Taussig shunt (MBTS) connects the innominate or carotid artery to the pulmonary artery. The right ventricle-pulmonary artery shunt (RVPAS) connects the RV directly to the pulmonary artery. 2 Both use a valveless tube graft for these connections. There are potential advantages and disadvantages to each shunt type. 3 The Pediatric Heart Network 4 Single Ventricle Reconstruction (SVR) trial compared outcomes in 549 infants undergoing a Norwood proce-
dure randomized to either MBTS or RVPAS at 15 North American centers. 5 The primary result of the trial found better 1-year transplant-free survival in subjects who received a RVPAS compared with those who had a MBTS.
Clinical Perspective on p 2638
As part of the SVR trial, 2-dimensional (2D) echocardiography was evaluated by a central core laboratory. Echocardiographic indices were measured to assess the effect of MBTS versus RVPAS at 4 stages during the trial (baseline preoperative examination, early after the Norwood procedure, immediately before the stage II procedure, and at 14 months of age). The primary SVR trial result publication 5 identified higher RV ejection fraction early after the Norwood procedure in the cohort who received a RVPAS compared with a MBTS with the use of the bipyramidal method for estimation of RV volumes 6 (as described in the online-only Data Supplement). No differences in the percentage of subjects with moderate to severe tricuspid regurgitation were identified between shunt types at any stage. We sought to analyze this database to more fully characterize the SVR cohort using all collected echocardiographic indices and specifically to (1) describe 2D baseline anatomic features and RV functional status of the cohort before the Norwood procedure and (2) compare the effect of shunt type on 2D and Doppler indices of RV function, cardiac and vascular dimensions, valve annulus dimensions and function, and neoaortic flow patterns early after the Norwood procedure, before the stage II procedure, and at 14 months of age.
Methods

Study Design
The SVR study design, 7 primary outcome (incidence of death or cardiac transplantation at 12 months after randomization), and secondary outcomes (morbidity during hospitalizations for the Norwood and stage II procedures, unintended cardiovascular interventions and rate of serious adverse events through 12 months, and angiographically derived pulmonary artery size before the stage II procedure) have been published previously. 5 Secondary markers of outcome with the use of echocardiography were also part of the study design and are summarized in the online-only Data Supplement; with regard to echocardiographic measures, only data on RV ejection fraction and the percentage of subjects with moderate or severe tricuspid regurgitation have been published previously for the cohort. 5
Echocardiographic Analysis
An echocardiography core laboratory at the Medical College of Wisconsin reviewed 2D/Doppler echocardiograms performed at each clinical center to compare indices between shunt groups at 4 predesignated time intervals during the study, as follows: (1) baseline (before the Norwood procedure); (2) after the Norwood procedure (either at time of discharge or at Ϸ30 days of age if still hospitalized); (3) before stage II (during the preoperative evaluation for the stage II procedure); and (4) at 14 months of age (end of study visit).
Before the trial was launched, all centers underwent training in the established protocol for performing the 2D and Doppler measures from standard imaging planes to ensure collection of complete information. Studies were preferentially captured and stored digitally with the DICOM format, transferred to the core laboratory on CD/DVD, and analyzed offline with a digital review system (TomTec Imaging Systems GmbH, Unterschleissheim, Germany) custom programmed for electronic caliper overlay of captured images and database storage of study-specific measures. Each study was analyzed initially by a pediatric echocardiography technician specifically trained in the protocol, and all indices were reviewed and confirmed by the director of the core laboratory, an experienced pediatric cardiologist with specialization in echocardiography (P.C.F.). The data set of measures obtained on each subject was electronically transferred to the Data Coordinating Center (New England Research Institutes, Watertown, MA) for statistical analyses. The echocardiographic measures and derived parameters obtained at each study are described in the online-only Data Supplement.
Statistical Analysis
Summary descriptive statistics of echocardiographic indices are presented by shunt type in place at the end of the Norwood operation at each interval. Distributions of echocardiographic indices were examined with normal probability plots and histograms. Continuous measures were compared between assigned shunt types with either Student or Welch t test or a Wilcoxon rank sum test as appropriate. Categorical measures were compared between shunt types with a Fisher exact test; ordinal measures were compared with a Fisher exact test and the Mantel-Haenszel test for trend. Given the number of echocardiographic indices that were examined, the Bonferroni multiple comparisons correction was used such that 2-sided P values Ͻ0.001 (Ͻ0.05/38 indices) were considered statistically significant. Analyses were performed in R version 2.12.0.
To adjust for the effect of somatic growth on the linear, area, and volumetric dimensions of cardiac structures, Z scores were used when normative data were available. 8 Because the neoaortic valve is not a native structure, the dimensions of this valve annulus were expressed as Z scores with the use of normal values for the dimensions of the native aortic valve in a normal population. These Z scores are calculated with respect to body surface area (BSA), with the power of BSA determined by prior work examining linearity between echocardiographic measures and various functions of BSA. 9 
Results
Of the 555 patients who were randomized in the SVR trial, 6 were excluded from this analysis (5 who did not undergo Norwood surgery and 1 who withdrew 1 week after the Norwood procedure), resulting in 549 patients who were available for evaluation. A total of 268 infants undergoing a Norwood procedure received the MBTS, and 281 infants received the RVPAS. Table 1 summarizes the expected number of patients available for echocardiography, the number of protocol echocardiograms obtained (the primary reasons for failure to obtain an echocardiogram were death or transplant, with a loss of Ϸ10% of the expected cohort at each stage), the number of acceptable protocol echocardiograms for analysis, and average age at the time of the protocol echocardiogram at each stage throughout the trial. Of submitted echocardiographic studies, 99% were deemed acceptable by the core laboratory for analysis.
Baseline Patient Characteristics
Baseline clinical characteristics, including anatomic diagnosis, number of patients with aortic atresia, number of patients with obstructed pulmonary venous return, and size of the ascending aorta measured from surgical inspection, have been published previously. 5 No baseline anatomic features or RV functional indices were different between shunt types before surgery ( Table 2 ). The median native ascending aorta diameter was 0.30 cm (interquartile range, 0.21-0.50 cm) with a median Z score of Ϫ3.8 (interquartile range, Ϫ4.5 to Ϫ2.4). A total of 375 subjects (69%) had an identifiable left ventricular cavity, with 226 (42%) having a patent aortic valve and 262 (49%) having a patent mitral valve. Overall, RV ejection fraction (46Ϯ9%) and area fraction change (35Ϯ9%) were calculated to be low. Moderate or severe tricuspid regurgitation was found in only 12% of the cohort preoperatively. Several of the measures, although not different between groups, could only be obtained in a small subset of the cohort because of inadequate/incomplete imaging (RV dP/dt, isovolumic acceleration) or because of fusion of the diastolic filling waves that commonly occurs in infants with sinus tachycardia (with resultant loss of an identifiable tricuspid inflow A and tricuspid Doppler tissue imaging AЈ wave as well as E/A ratio and EЈ/AЈ ratio calculations). 
Cardiac and Vascular Anatomic Dimensions
RV shape as assessed by eccentricity index and RV size as assessed by area and volume analysis were not significantly different between shunt groups at any interval (Table 4 ). Trends toward smaller end-diastolic and end-systolic RV volumes were seen in the RVPAS group at both the post-Norwood and pre-stage II studies, but these differences disappeared at the 14-month visit. Left pulmonary artery diameter (0.39Ϯ0.09 versus 0.42Ϯ0.11 cm; PϽ0.001) and Z score (Ϫ1.12Ϯ1.07 versus Ϫ0.71Ϯ1.26; PϽ0.001) were smaller in the MBTS group at the post-Norwood assessment, but no other pulmonary artery or neoaortic anatomic measure was significantly different at any postoperative stage between groups.
Neoaortic and Tricuspid Annular Dimensions and Valvar Function
Neoaortic and tricuspid annulus dimensions and areas were significantly greater than normal in both shunt groups, with Z scores ranging from 3 to 7 (Table 5 ). After the Norwood procedure, neoaortic valve annular area (4.21Ϯ1.13 versus 4.64Ϯ1.16 cm 2 /BSA; PϽ0.001) and anteroposterior diameter (2.26Ϯ0.36 versus 2.38Ϯ0.35 cm/͌BSA; PϽ0.001) and their corresponding Z scores ( Figure 1 ) were significantly smaller in the RVPAS group than in the MBTS group. Neoaortic annular dimension Z scores remained significantly smaller before stage II in the RVPAS group (PϽ0.001), but the differences were no longer statistically significant at 14 months. Significant neoaortic regurgitation, graded as moderate or severe, was uncommon (Յ3%) and was not different between shunt types at 14 months. Tricuspid valve size and degree of regurgitation were similar in the 2 groups at all postoperative intervals, with 20% of the MBTS and 23% of the RVPAS cohort having moderate or severe regurgitation at 14 months.
Neoaortic Flow Patterns
All indices of neoaortic flow (cardiac index, ejection time, and peak distal arch velocity) were significantly lower in 
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the RVPAS than in the MBTS group ( Figure 2 ) at both interstage studies (after Norwood and before stage II; PϽ0.001). In addition, the percentage of retrograde diastolic flow in the thoracic descending neoaorta was significantly increased in the MBTS group compared with the RVPAS, both after the Norwood procedure (median [interquartile range] 43% [33-54%] versus 0% [0 -0%]; PϽ0.001) and before stage II (39% [31-50%] versus 0% [0 -0%]; PϽ0.001). All neoaortic flow indices were similar for the 2 shunt types at age 14 months.
Subanalysis of Subjects Alive at 14 Months
To investigate the possibility of survivor bias, all 2D/Doppler indices were reexamined in the subgroup of subjects alive at 14 months who had echocardiographic studies deemed acceptable at all 3 postbaseline time points (nϭ329). The direction of shunt effect was consistent, and all indices found significant for the entire cohort remained statistically significant in this subgroup at all intervals ( 
Discussion
This SVR study demonstrates that initial shunt type for the Norwood procedure does not affect echocardiographic indices measured after shunt removal at 14 months of age, including RV systolic, diastolic, and global function, cardiac and vascular dimensions, neoaortic and tricuspid annular dimensions and valve function, and neoaortic flow patterns. Previous single-center studies in children with hypoplastic left heart syndrome comparing shunt types have been limited by relatively small sample size with qualitative or incomplete quantitative assessment of RV fractional area change and have presented conflicting results. Hughes et al 10 identified better early postoperative RV systolic function after RVPAS compared with MBTS, whereas others found either no difference between shunt groups 11, 12 or decreased RV function early after RVPAS. 13 The few studies in which more innovative echocardiographic techniques were used to assess RV function after the Norwood procedure, including dP/dt from the tricuspid regurgitation jet, 14 tricuspid annular Doppler tissue imaging, 11, 15 indices of diastolic function, 11 and the MPI, 11 have also been limited by small sample size at a single center. In contrast, this study is the first multicenter trial specifically designed to compare echocardiographic indices in a large cohort of patients randomized to receive either a RVPAS or MBTS at initial palliation. 7 Moreover, comparison of baseline anatomic features and RV functional status of the SVR trial subjects before Norwood palliation shows an appropriately randomized cohort with no significant differences between the MBTS and RVPAS groups before surgery. There were relatively few interstage differences in echocardiographic indices between shunt types, and many of these differences could be explained by the different physiologies created by the shunts. Smaller neoaortic annular dimensions, shorter neoaortic systolic ejection times, lower neoaortic cardiac index, decreased peak aortic arch velocities, and increased blood flow-calculated MPI were found in the RVPAS compared with the MBTS group. These findings are consistent with diminished flow across the neoaortic valve and can be explained at least in part by the physiology of the RVPAS. With the RVPAS in place, a portion of the RV output flows directly into the pulmonary bed via the conduit rather than across the neoaortic valve; this is in contrast to MBTS patients, in whom all RV output must flow across the neoaortic valve. A shortened neoaortic ejection time after the Norwood procedure in patients with the RVPAS compared with the MBTS has been described previously, 11 with early neoaortic valve closure likely secondary to more rapid systolic pressure decay as the RV is able to eject into both the pulmonary and systemic vascular beds. This difference in flow is expected as part of the unique physiology of the RVPAS rather than a pathological change reflecting myocardial disease, and this difference likely explains and invalidates the higher interstage MPI values found in the RVPAS cohort with the use of blood flow calculations (because of the shortened neoaortic ejection time). Indeed, when MPI was calculated from myocardial tissue Doppler indices instead of blood flow, no significant differences were noted between groups at any stage.
Although the lack of differences in cardiac size and function at 14 months suggests that the impact of the initial shunt physiology appears to diminish over time after shunt removal, the window of observation in this study was short. Previous single-center studies comparing outcome in later childhood between shunt types again provide conflicting results. Despite better early survival with the RVPAS compared with the MBTS, several reports have identified poorer qualitative RV systolic function before and after the final- stage Fontan palliation in patients who had the RVPAS. 16, 17 The RVPAS requires a ventriculotomy that could potentially affect ventricular performance because of myocardial injury, scar, or aneurysm formation. 18 The increased prevalence of reversal of pulmonary vein flow with atrial contraction and a trend toward smaller ventricular volumes in the RVPAS group at the post-Norwood study may reflect more restrictive diastolic function as a result of the ventriculotomy early after surgery, similar to findings in infants early after tetralogy of Fallot repair. 19 The impact of shunt type after subsequent palliations remains unclear, however, and a recent report found no shunt-related difference in RV function after Fontan but worse tricuspid valve function in MBTS patients. 20 In this cohort, differential neoaortic annulus growth related to shunt type diminished at 14 months. Not surprisingly, the neoaortic annulus remained dramatically dilated in both shunt groups at all stages compared with normal controls. Other studies have reported the development of significant neoaortic root dilatation and neoaortic valve insufficiency late after Norwood palliation with a MBTS. 21 This study may not have been of sufficient duration to know whether this cohort will show the same degree of progressive disease. Similarly, despite the lack of important differences in echocardiography-derived measures of the pulmonary arteries (the only statistically significant difference being the left pulmonary artery size discrepancy of 0.39 versus 0.42 cm after the Norwood procedure) and distal aortic arch size at 14 months in this cohort, the impact of shunt type on late vascular growth remains unclear.
This cohort provides a unique opportunity for longitudinal follow-up, and continued monitoring of SVR trial survivors is already in place. A Pediatric Heart Networksponsored SVR extension study is ongoing, designed to provide additional clinical and echocardiographic surveillance through age 6 years, with protocol echocardiograms obtained within 6 months of Fontan palliation and at 6 years of age. This extension should help to identify longer-term effects of initial shunt type on echocardio-graphic indices of cardiac, valvar, and vascular size and function as this cohort progresses through Fontan palliation, and it is anticipated that these children will continue to be monitored into adolescence and adulthood.
Study Limitations
Unlike for the left ventricle, 2D echocardiographic tools for assessment of RV volume and systolic functional assessment remain limited secondary to the complex geometry of the chamber. The biplane pyramidal method for RV size assessment used here (see the online-only Data Supplement) has been shown to correlate well with RV ejection fraction estimates derived from cardiac magnetic resonance imaging in children with and without congenital heart disease, and it appears to provide the most accurate estimate of RV volume compared with other described 2D echocardiographic RV volume methods. 6 Of note, analysis of regional RV wall motion was not performed as part of this protocol, and therefore the impact of focal scarring/dyskinesis was not specifically assessed.
Careful training in protocol image acquisition was provided and reinforced at all sites with regular quality assurance feedback from the core laboratory to optimize appropriate image capture, and 99% of the submitted studies were found to be acceptable in providing images that allowed data extraction. However, more innovative measurements such as RV dP/dt and tricuspid annular isovolumic acceleration were not possible in the majority of studies because of incomplete or inadequate image acquisition. The impact of this limitation in the characterization of RV function for the SVR cohort is unclear but emphasizes the challenge of multi-institutional echocardiographic trials that require extensive data acquisition, particularly when those data are obtained from infants with complex heart disease.
Conclusions
Indices of RV function, cardiac and vascular dimensions, valve annular dimensions and function, and neoaortic flow patterns in survivors of the Norwood procedure are similar Figure 1 . Box plots are shown by shunt type at all 4 intervals for neoaortic valve annular area Z scores (A; pre-Norwood, nϭ473; post-Norwood, nϭ452; pre-stage II, nϭ369; 14 months, nϭ308) and neoaortic anteroposterior (AP) valve annulus diameter Z scores (B; pre-Norwood, nϭ521; post-Norwood, nϭ463; pre-stage II, nϭ380; 14 months, nϭ319). Z scores for both neoaortic area and diameter are significantly smaller in the right ventricle-pulmonary artery shunt (RVPAS) group compared with the modified Blalock-Taussig shunt (MBTS) group (PϽ0.001) after Norwood and before stage II but are not significantly different at baseline and 14 months.
for subjects with MBTS and RVPAS by 14 months of age. Interstage differences in neoaortic annular size and flow patterns between shunt types can likely be explained by the different physiologies created when the shunts are in place rather than by intrinsic differences in myocardial and valve function. Longitudinal follow-up of the cohort is ongoing and will likely provide further insights into the long-term effect of initial shunt type on clinical outcome and echocardiographic indices of cardiac size and function. Figure 2 . Box plots are shown by shunt type at all 4 intervals for neoaortic cardiac index (A; pre-Norwood, nϭ327; post-Norwood, nϭ397; pre-stage II, nϭ330; 14 months, nϭ286), neoaortic ejection time (B; pre-Norwood, nϭ363; post-Norwood, nϭ419; pre-stage II, nϭ353; 14 months, nϭ303), and neoaortic peak distal arch velocity (C; post-Norwood, nϭ355; pre-stage II, nϭ298; 14 months, nϭ264). All 3 neoaortic flow indices are significantly different (PϽ0.001) after Norwood and before stage II, with decreased cardiac index, ejection time, and peak distal arch velocity in the right ventricle-pulmonary artery shunt (RVPAS) compared with the modified Blalock-Taussig shunt (MBTS) group, but these indices were not significantly different at baseline and 14 months.
